First Time Loading...

Kissei Pharmaceutical Co Ltd
TSE:4547

Watchlist Manager
Kissei Pharmaceutical Co Ltd Logo
Kissei Pharmaceutical Co Ltd
TSE:4547
Watchlist
Price: 3 535 JPY -0.7% Market Closed
Updated: Mar 28, 2024

Intrinsic Value

Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. [ Read More ]

The intrinsic value of one Kissei Pharmaceutical Co Ltd stock under the Base Case scenario is 48 250.38 JPY. Compared to the current market price of 3 535 JPY, Kissei Pharmaceutical Co Ltd is Undervalued by 93%.

Key Points:
Intrinsic Value
Base Case
48 250.38 JPY
Undervaluation 93%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

Financials

Balance Sheet Decomposition
Kissei Pharmaceutical Co Ltd

Current Assets 102.2B
Cash & Short-Term Investments 43.2B
Receivables 29.5B
Other Current Assets 29.5B
Non-Current Assets 126.2B
Long-Term Investments 80B
PP&E 24.6B
Intangibles 1.9B
Other Non-Current Assets 19.7B
Current Liabilities 17.2B
Accounts Payable 4.8B
Accrued Liabilities 803m
Short-Term Debt 1.4B
Other Current Liabilities 10.2B
Non-Current Liabilities 14.7B
Other Non-Current Liabilities 14.7B
Efficiency

Earnings Waterfall
Kissei Pharmaceutical Co Ltd

Revenue
73.7B JPY
Cost of Revenue
-38.2B JPY
Gross Profit
35.6B JPY
Operating Expenses
-33B JPY
Operating Income
2.5B JPY
Other Expenses
9.7B JPY
Net Income
12.2B JPY

Free Cash Flow Analysis
Kissei Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

Profitability Score
Profitability Due Diligence

Kissei Pharmaceutical Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive Net Income
ROE is Increasing
46/100
Profitability
Score

Kissei Pharmaceutical Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Kissei Pharmaceutical Co Ltd's solvency score is 95/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
95/100
Solvency
Score

Kissei Pharmaceutical Co Ltd's solvency score is 95/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Kissei Pharmaceutical Co Ltd

Wall Street analysts forecast Kissei Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Kissei Pharmaceutical Co Ltd is 3 725.55 JPY with a low forecast of 3 181.5 JPY and a high forecast of 4 830 JPY.

Lowest
Price Target
3 181.5 JPY
10% Downside
Average
Price Target
3 725.55 JPY
5% Upside
Highest
Price Target
4 830 JPY
37% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Kissei Pharmaceutical Co Ltd

1M 1M
+5%
6M 6M
+4%
1Y 1Y
+38%
3Y 3Y
+44%
5Y 5Y
+38%
10Y 10Y
+63%
Annual Price Range
3 535
52w Low
2 557.8738
52w High
3 700
Price Metrics
Average Annual Return 0.88%
Standard Deviation of Annual Returns 18.99%
Max Drawdown -35%
Shares Statistics
Market Capitalization 157.1B JPY
Shares Outstanding 44 253 600
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Kissei Pharmaceutical Co Ltd Logo
Kissei Pharmaceutical Co Ltd

Country

Japan

Industry

Pharmaceuticals

Market Cap

157.1B JPY

Dividend Yield

2.3%

Description

Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. The company is headquartered in Matsumoto-Shi, Nagano-Ken and currently employs 1,863 full-time employees. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The firm is engaged in the collection and analysis of medicine development information, and the manufacture and sale of medicines. The company is also engaged in the purchase and sale of related materials, system development and information process work, construction contract work such as new construction, expansion and renovation of factories, laboratories and offices, the management of facility and equipment work, information collection and development support work, noodle manufacture and sale, and insurance agency business.

Contact

NAGANO-KEN
Matsumoto-shi
19-48, Yoshino
+81263259081.0
http://www.kissei.co.jp/

IPO

1988-12-22

Employees

1 863

Officers

Chairman & CEO
Mr. Mutsuo Kanzawa
President, COO & Director
Mr. Yasuo Takehana
GM of Financial Management Department, MD & Director
Mr. Takahide Kitahara
Senior Advisor & Director
Mr. Yoshio Furihata
Executive VP & Director
Mr. Keiji Fukushima
Executive MD & Director
Mr. Tetsu Takayama
Show More
GM of Pharmaceutical Sales Headquarters & Director
Hiroshi Noake
GM of Research Division & Director
Keiji Miyazawa
Show Less

See Also

Discover More